EVP & President, Commercial Kendrick Charles Morgan JR executed a sale of 7,417 shares of Elevance Health Inc (ELV, Financial) on October 18, 2024, as reported in a recent SEC Filing. Following this transaction, the insider now owns 8,423 shares of the company.
Elevance Health Inc operates as a health benefits company in the United States. It is dedicated to improving lives and communities and making healthcare simpler through its affiliated companies which provide a range of health-related products and services.
Over the past year, Kendrick Charles Morgan JR has sold a total of 9,849 shares of the company and has not made any purchases. The recent transaction reflects a continuation of this selling trend among insiders at Elevance Health Inc, with a total of 11 insider sales and no insider buys over the past year.
On the valuation front, shares of Elevance Health Inc were priced at $432.14 on the day of the transaction. The company has a market cap of approximately $99.91 billion. The price-earnings ratio stands at 15.70, which is slightly below the industry median of 15.86 and the company's historical median.
The stock's GF Value is estimated at $545.87, indicating that Elevance Health Inc is modestly undervalued with a price-to-GF-Value ratio of 0.79.
The GF Value is calculated considering historical multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This insider sale could be of interest to investors tracking insider behaviors and evaluating the stock's valuation metrics in relation to its current trading price.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
